Company intelligence / Profile preview

Voximetry

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Voximetry is a health technology company specializing in personalized dosimetry for radiopharmaceutical therapies (RPT). The company's flagship product, Torch, is a cloud-based software platform that provides patient-specific dose calculations to optimize treatment for late-stage cancer patients. By utilizing advanced Monte Carlo simulations and image processing, Voximetry enables clinicians to tailor radiation doses to individual patient anatomy and tumor biology. The company aims to improve the efficacy and safety of targeted radionuclide therapies, such as those targeting PSMA and somatostatin receptors.

Therapeutic areas: Oncology
Modalities: Device
Industry: Medical Imaging

Partnerships

NorthStar Medical Radioisotopes

Beyond the preview

Go deeper on Voximetry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voximetry.

Explore the full profile